Cutaneous Adverse Events of Osimertinib in Diverse Patient Populations with EGFR-mutated Non-Small Cell Lung Cancer: A Retrospective Cohort Analysis

Name: Cutaneous Adverse Events of Osimertinib in Diverse Patient Populations with EGFR-mutated Non-Small Cell Lung Cancer: A Retrospective Cohort Analysis
Creator: Daniel Alicea
Published: 2024-11-07T13:57:42.059Z
Keywords: Dermatology, Oncology

Alicea, Daniel; Miao, PharmD, MD, Emily; Ch'en, Peter; Tuckman, MBA, Steven W.; Ohri, MD, MS, Nitin; Halmos, MD, Balazs; Cheng, MD, PhD, Haiying; Lee, MD, MPH, Matthew; McLellan, MD, Beth N.

doi:10.17632/87nhm59g4t.1

Cutaneous Adverse Events of Osimertinib in Diverse Patient Populations with EGFR-mutated Non-Small Cell Lung Cancer: A Retrospective Cohort Analysis

Published: 7 November 2024| Version 1 | DOI: 10.17632/87nhm59g4t.1

Contributors:

Daniel Alicea,

,

Description

A Kaplan Meier curve seen in supplemental Figure 1 was conducted to assess overall survival (OS) among racial/ethnic groups; results showed that Non Hispanic Whites and Asians have a longer OS compared to Non Hispanic Blacks and Hispanics/Latinos (p=0.026).

Files

Steps to reproduce

Kaplan-Meier curves were generated for overall survival and log-rank test compared the curves between patients.

Cutaneous Adverse Events of Osimertinib in Diverse Patient Populations with EGFR-mutated Non-Small Cell Lung Cancer: A Retrospective Cohort Analysis

Description

Files

Steps to reproduce

Categories

Licence